The senior staff of The University of Iowa Pharmaceuticals has the experience required to successfully provide the services you need.
Mick graduated from the University of Iowa College of Pharmacy in 1990 with a Ph.D. in pharmaceutics (major professor Eugene L. Parrott, Ph.D.) and B.S. in pharmacy in 1987. He began working at Glaxo in 1991 as a Senior Scientist. For 16 years, Mick worked in product development at Glaxo/GlaxoWellcome/GlaxoSmithKline. Mick played a key role in the development of several commercial products including Wellbutrin SR 100 and 200 mg Tablets, Wellbutrin XL 150 and 300 mg Tablets, Epivir Oral Liquid, Zantac 25 mg Effervescent Tablets, and Zantac Soft Gelatin Capsules. Also during this time he served as an Adjunct Assistant Professor in Pharmaceutical Sciences at Campbell University School of Pharmacy, was named co-inventor on numerous patent applications, wrote several book chapters, published numerous papers, and presented numerous podium and poster presentations. In 2008 he joined the University of Iowa Division of Pharmaceutical Service (now known as The University of Iowa Pharmaceuticals) as Director. In addition to his responsibilities as Director of The University of Iowa Pharmaceuticals he is also an Associate Professor of Pharmaceutics.
DIRECTOR, Analytical Laboratories
Samantha graduated from the University of Northern Iowa with a B.S. in Chemistry in 1994. In 1994 she joined Salsbury Chemicals, an active pharmaceutical ingredient and fine chemical manufacturer, more recently known as Cambrex, in Charles City, IA as a Quality Assurance Laboratory Technician. As a laboratory technician, she was responsible for analytical testing of a variety of fine chemicals, pharmaceutical intermediates, and APIs. In 1997, Samantha moved to the Chemical Development group where she was involved in the development of manufacturing processes for various fine chemicals, pharmaceutical intermediates and APIs. In this role Sam worked on chemical processes from the development stage through full-scale production under cGMP regulations. Her responsibilities included preparation of manufacturing records and production troubleshooting. Sam has been involved in potent compound handling in both a laboratory setting and production environment. In 2001, Sam moved back to the Quality Control Group as an Assistant Scientist/Stability Program Coordinator. In 2003, she joined the University of Iowa Division of Pharmaceutical Service (now known as The University of Iowa Pharmaceuticals) as a Chemist in the Methods Development, Validation, and Preformulations Group. She is now the director of this group as well as the entire analytical laboratory.
Dave graduated from the University of Iowa College of Pharmacy in 1992 with a B.S. in pharmacy and is a licensed pharmacist. After obtaining his pharmacy degree in 1992, he began working for the University of Iowa Division of Pharmaceutical Service (now known as The University of Iowa Pharmaceuticals) in the Sterile Products Group as a Staff Pharmacist. Throughout his career of over 20 years, Dave has been responsible for the manufacturing of sterile products for both clinical and commercial use. Dave specializes in aseptic processing, Clean Room operations, lyophilization scale-up and safe handling of potent compounds. This includes responsibility for the manufacture of many lyophilized products, which often entails working with clients to develop and optimize lyophilization cycles, and ongoing validation of Sterile Products equipment and processes. Dave is the DEA Compliance Officer for The University of Iowa Pharmaceuticals and is responsible for ensuring regulatory compliance with all controlled substances manufactured in the facility.
Director, Preformulation and Formulation Development
Ram received his B. Pharm. Sci. degree (1995) and, M. Pharm. Sci. degree (1997) in Pharmaceutics from the University of Mumbai. Ram graduated with a PhD in Pharmaceutics (2002) from the University of Mumbai. In 2002, Ram joined the University of Minnesota as a Post-Doctoral Associate in the Department of Pharmaceutics where he worked till 2006. In 2006, Ram joined GlaxoSmithKline where, in different roles, he was responsible for preformulation, formulation & process development for drug products of new chemical entities, and product line extensions. During his time at GlaxoSmithKline, he was also appointed Adjunct Assistant Professor in the Department of Molecular Pharmaceutics at UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, North Carolina. In 2015 Ram joined the University of Iowa Pharmaceuticals. In addition to his responsibilities in the Preformulation Division of The University of Iowa Pharmaceuticals, he is also a Clinical Assistant Professor of Pharmaceutics in the College of Pharmacy.
robin A. rossignol
Director, laboratory quality
In 1987, Robin earned a Master of Science degree in Forensic Chemistry from Northeastern University, Boston, MA. From 1989 to mid 1992 Robin worked in the greater Boston area for a contract manufacturer of commercial aerosol drug products as a QC Chemist, then as Manager of the QC Laboratory. In mid 1992 she joined a Boston area start-up biotechnology company as their QA Manager. Some of the activities she was responsible for included: writing SOPs, sourcing vendors, managing and auditing contract manufacturers, clinical packagers, and GLP toxicology laboratories, writing and approving validation protocols for laboratory equipment. In 1995 Robin joined the Center for Advanced Drug Development as the QA Manager and the Division of Pharmaceutical Services in QA to oversee laboratory quality. The two groups later merged to become the University of Iowa Pharmaceuticals. She is currently responsible for laboratory quality at the UIP PRL site.
Jeffrey J. Millard
Manager, Manufacturing Quality
Jeff graduated with a B.S. in Cell Biology from the University of Iowa in 1993. He began working for the University of Iowa Division of Pharmaceutical Service (now known as The University of Iowa Pharmaceuticals) in 1991. Jeff started working in the analytical laboratory performing in-process, finished product and stability analyses of various pharmaceutical products including sterile injectables, oral liquids and solids, and topical ointments, creams, and solutions. From 1997 to 2011 he worked as a supervisor and then manager in the analytical laboratory. In 2011 he was transferred to Manufacturing Quality Assurance as a manager and has worked with the Director for Manufacturing Quality and assisted in supervising the quality assurance programs associated with drug product manufacturing and testing.
Bill graduated with a B.S. in pharmacy from the University of Iowa College of Pharmacy in 1987. He is a licensed pharmacist. He began working for the University of Iowa Division of Pharmaceutical Service (now known as The University of Iowa Pharmaceuticals) in 1987 in the Solid Dosage Forms Group as a Staff Pharmacist. He has spent over 20 years developing formulations and manufacturing solid oral dosage forms for use in clinical trials and commercial sale. In addition to his responsibilities as the head of the Solid Dosage Forms area, he oversees the General Manufacturing Group which formulates and manufactures topical ointments, creams, gels and oral liquids for clinical use. Bill is also responsible for overseeing facilities maintenance for the group.
Randy graduated from the University of Iowa College of Pharmacy in 1986 with a B.S. in pharmacy. He is a licensed pharmacist. He began working for The Upjohn Company in 1986 in their Pharmacy Research Group as a Research Pharmacist. The focus of his work there was the development of drug candidates from pre-IND stage through production phase-in. In this capacity he gained extensive experience with the development of hydrophilic matrix sustained release tablets, various techniques used to enhance the solubility of poorly soluble compounds, the use of injection molding to prepare solid oral dosage forms, the formulation of compressed protein matrices, and the preparation of hot melt filled hard gelatin capsules. In 1991 he joined Fort Dodge Animal Health, a Division of American Home Products, as Manager of Pharmaceutical Production. In this role he was responsible for the transfer of pharmaceutical production operations into a newly built facility. Once this work was completed he became the Director of Pharmaceutical Development and Analytical Services. In 1993 he began working for the University of Iowa Division of Pharmaceutical Service (now known as The University of Iowa Pharmaceuticals) in the Solid Dosage Forms Group as a Staff Pharmacist. He has spent the last 15 years developing formulations and manufacturing solid oral dosage forms for use in clinical trials. During this time he obtained his M.B.A. for the University of Iowa College of Business. In 2008 a new Business Development Group was created at The University of Iowa Pharmaceuticals and Randy was appointed to lead it. In addition to his duties as part of UIP Randy is an Adjunct Assistant Professor of Pharmaceutics.